Evaluation of GP-centred care in the German state of Thuringia

GP-centered care evaluation in the state of Thuringia: a retrospective case-control intervention study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN29418540

Enrollment

40000

Registered

2014-06-17

Start date

2012-07-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GP-centered health care programme Not Applicable

Interventions

Group 1 = GP-centred programme: participants receive total coordinated health care over 18 months. The GP-centred health care programme includes morbidity lump sums, bonuses for rational pharmacothera

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients living in Thuringia 2. Beneficiaries to the statutory health insurance fund AOK PLUS 3. Entry into GP-centered health care programme between 01/01/2011 and 30/06/2011

Exclusion criteria

Exclusion criteria: Patients aged < 18

Design outcomes

Primary

Measure	Time frame
Direct total health care costs to the sickness funds (in-patient hospital care, outpatient physician care, drugs, remedies, therapeutic aids, sick leave payment, home care, rehabilitation, post-acute care) - measured after 18 months	—

Secondary

Measure	Time frame
1. Share of patients with different GPs contacted 2. Share of patients with different specialists contacted 3. Share of specialist contacts without referal 4. Share of hospital procedures with potential of substitution by outpatient prodcedure 5. Number of hospital emergency cases 6. Number of home visits by GPs 7. Development of nursing care status 8. Number of prevention procedures by GPs 9. Number of different drugs (ATC Code) 10. Share of patients with polymedication (>5 drugs) 11. Share of patients older than 64 years with polymedication (>5 drugs) 12. Costs of hospital care cases 13. Number of in-patient cases 14. Costs of GP contacts 15. Number of GP contacts 16. Costs of specialist contacts 17. Number of specialist contacts 18. Costs of home care 19. Number of home care prescriptions 20. Costs of remedies 21. Number of remedies prescripted 22. Costs of therapeutic aids 23. Number of therapeutic aids prescripted 24. Costs of rehabilitation (in- and outpatient) 25. Number of rehabilitation prescripted (in- and outpatient) 26. Costs of subsequent nursing treatment 27. Number of subsequent nursing treatment prescriptions 28. Costs of sick leave payment 29. Number of cases of sick leave and days of sick leave 30. Costs of drug prescriptions 31. Number of drug prescriptions All to be measured after 18 months	—

Measure

Time frame

1. Share of patients with different GPs contacted 2. Share of patients with different specialists contacted 3. Share of specialist contacts without referal 4. Share of hospital procedures with potential of substitution by outpatient prodcedure 5. Number of hospital emergency cases 6. Number of home visits by GPs 7. Development of nursing care status 8. Number of prevention procedures by GPs 9. Number of different drugs (ATC Code) 10. Share of patients with polymedication (>5 drugs) 11. Share of patients older than 64 years with polymedication (>5 drugs) 12. Costs of hospital care cases 13. Number of in-patient cases 14. Costs of GP contacts 15. Number of GP contacts 16. Costs of specialist contacts 17. Number of specialist contacts 18. Costs of home care 19. Number of home care prescriptions 20. Costs of remedies 21. Number of remedies prescripted 22. Costs of therapeutic aids 23. Number of therapeutic aids prescripted 24. Costs of rehabilitation (in- and outpatient) 25. Number of rehabilitation prescripted (in- and outpatient) 26. Costs of subsequent nursing treatment 27. Number of subsequent nursing treatment prescriptions 28. Costs of sick leave payment 29. Number of cases of sick leave and days of sick leave 30. Costs of drug prescriptions 31. Number of drug prescriptions All to be measured after 18 months

—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026